United States Anticoagulant Pharmaceutical Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Anticoagulant Pharmaceutical Markets, Executive SummaryIntroduction to the U.S. Anticoagulant Pharmaceutical MarketObjectives and PurposeReport Scope and SegmentationReport Structure Summary of Major FindingsAnalysis by Major SegmentsCompetitive AnalysisUnited States Anticoagulant Pharmaceutical Markets, Market Engineering Research MethodologyResearch ScopeObjectives and PurposeReport Structure and Market SegmentationMarket Engineering Forecasting MethodologyOverviewStrategic Significance of the Market Engineering ForecastJudging Credibility and Accuracy of Market Engineering ForecastsForecast AssumptionsGlossary of TermsList of DefinitionsList of AcronymsUnited States Anticoagulant Pharmaceutical Markets, Industry ChallengesIdentification of Challenges Facing the Anticoagulant IndustryIdentification of Challenges Facing the Anticoagulant IndustryAbolishment of Negative Formulary Could Prove Detrimental to Brand CompaniesNovel Delivery Technologies Require Companies to Seek Alliances to Retain Market Position Maturing Product Life-Cycle Demands Companies Look for Alternative OptionsExpanded Product Indications Could Delay Entry of Generics Market Engineering Research for the U.S. Anticoagulant Pharmaceutical Market 1996-2006Market Overview and DefinitionsOverviewScope and SegmentationDisease OverviewMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1996-2006)Competitive StructureMarket Engineering Research for the U.S. Oral Anticoagulant Pharmaceutical Market 1996-2006Market Overview and DefinitionsOverviewDefinitionScope/SegmentationHistory Market Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1996-2006)Pricing Strategy and Trend AnalysisCompetitive StructureMarket Engineering Research for the U.S. Injectable Anticoagulant Pharmaceutical Market 1996-2006Total Market Analysis (U.S.)Market Overview and DefinitionsMarket Engineering Revenue Forecasts (1996-2006)Revenue Trends by Product TypeCompetitive AnalysisCompetitive StructureStrategic Analysis and Forecasts of the Low Molecular Weight Heparin (LMWH) MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1996-2006)Pricing Trend AnalysisCompetitive StructureStrategic Analysis and Forecasts of the Unfractionated Heparin MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1996-2006)Pricing Trend AnalysisCompetitive StructureUnited States Anticoagulant Pharmaceutical Markets, Market Engineering StrategyMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsCorporate Management Marketing DepartmentMarket Engineering Awards for the Anticoagulant MarketFrost & Sullivan's 2000 Market Engineering AwardsFrost & Sullivan's 2000 Market Engineering AwardsMarket Engineering AwardsMarket Engineering AwardsAward Category: Entrepreneurial Company Award Category: Competitive Strategy




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 21-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.